4-Isopropyl-2,6-dimethyl-1,3,5-dithiazinane
Common Name: |
4-Isopropyl-2,6-dimethyl-1,3,5-dithiazinane |
IUPAC Name: |
2,4-dimethyl-6-propan-2-yl-1,3,5-dithiazinane |
Molecular Formula: |
C9H19NS2 |
SMILES: |
CC1NC(SC(S1)C)C(C)C |
Inchi: |
1S/C8H17NS2/c1-5(2)8-9-6(3)10-7(4)11-8/h5-9H,1-4H3 |
Inchi Key: |
NOOYZCFJVKLILW-UHFFFAOYSA-N |
Cas No: |
104691-41-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
205.38 |
Mass (g/mol) |
191.08 |
Molar Refractivity |
65.16 |
Net Charge |
|
HBD |
1 |
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
62.63 |
Hetero Atoms |
3 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
285.00 to 286.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.003 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
2.73 |
iLOGP |
2.68 |
XLOGP3 |
3.78 |
WLOGP |
2.74 |
MLOGP |
2.15 |
ESOL Log S |
-3.36 |
ESOL Solubility (mg/ml) |
0.089 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.79 |
Ali Solubility (mg/ml) |
0 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-2.30 |
Silicos-IT Solubility (mg/ml) |
1.03 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.87 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.675 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.167 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |